Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

Greg Meyers, Executive Vice President and Chief Digital &amp; Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma. 

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Eureka!

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

Bayer’s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.

Bayer&rsquo;s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.

Bayer’s Sai Jasti on driving productivity in R&D with data science and AI 

Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin shares how Boehringer Ingelheim&rsquo;s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin on the cutting edge of clinical trial design

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

In 1 playlist(s)

Eureka!

Social links

Follow podcast

Recent clips